TP53 and non-small cell lung carcinoma: We next utilized the pharmacological USP10 inhibitor, P2207714, to inhibit USP10 in six NSCLC cell lines harboring null- or mutant-p53 (H358, H522, H1975, H322, H661, and H2122) to examine cell viability by MTT assays.